It has been demonstrated that a proportion of the CEA metabolized by the liver subsequently enters the bile, thereby indicating that cholestasis-inducing conditions may also contribute to an increase in CEA levels in the blood [5,7]. The gene discussed is CEACAM5; the disease is cholestasis.